Moderna, Inc. (MRNA) has 13 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $5.3M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 14, 2026 | Hoge Stephen President | — | +72,330 | +31% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | Mock James M Chief Financial Officer | −$2,017,350 | 74,508 | −26% | Yes | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Mock James M Chief Financial Officer | — | +6,093 | +6% | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Klinger Shannon Thyme Chief Legal Officer | — | +6,093 | +6% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Mock James M Chief Financial Officer | — | +1,278 | +5% | No | |
|
|
||||||
Showing the 5 most recent of 13 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free